Synopsis
The Neurology podcast is introduced by Editor-in-Chief Robert A. Gross, MD, PhD, who discusses several highlighted articles in the current issue of Neurology®. The podcast regularly features content from Neurology® Clinical Practice, Neurology® Genetics, and Neurology® Neuroimmunology & Neuroinflammation. Opening segments include interviews with authors who summarize a current article and discuss the main findings and clinical implications for neurologists. Regular features also include the Lesson of the Week, Delayed Recall, Whats Trending, and selected content from Neurology® Today. Podcast listeners can earn 0.5 AMA PRA Category 1 CME Credits by answering the multiple-choice questions related to Neurology content in the online Podcast Quiz. (Delayed Recall, Neurology® Clinical Practice, Neurology® Genetics, and Neurology® Neuroimmunology & Neuroinflammation contents are excluded from the CME program). The exams are posted weekly on Tuesday.
Episodes
-
A Nationwide Cohort Study of Epilepsy-Related Death in Young People
17/01/2022 Duration: 15minDr. Halley Alexander discusses the utility of a new systematic classification of epilepsy-related mortality used in a nationwide cohort study of children and young adults in Denmark with Dr. Marius Kløvgaard.
-
The Amyloid Hypothesis for Alzheimer Disease and Aducanumab
13/01/2022 Duration: 17minDr. Jeff Burns discusses the amyloid hypothesis and the challenges clinicians face in navigating discussions on the use of aducanumab for Alzheimer disease with Dr. Erik Musiek.
-
Association Between Location of Epilepsy Surgery and Outcomes
10/01/2022 Duration: 20minDr. Halley Alexander talks with Dr. Ezequiel Gleichgerrcht about the association between the anatomical location of surgical lesions and postoperative seizure outcomes in patients with temporal lobe epilepsy.
-
Antiseizure Medication Withdrawal in Seizure-Free Patients
05/01/2022 Duration: 13minDr. Halley Alexander discusses the AAN Guideline Subcommittee’s practice advisory update on antiseizure medication withdrawal in seizure-free patients with Dr. Alison Pack.
-
White Matter MRI Sequelae of Repetitive Head Impacts
03/01/2022 Duration: 16minDr. Jeff Ratliff talks with Dr. Michael Alosco about the association between antemortem FLAIR white matter hyperintensities and neuropathology in brain donors exposed to repetitive head impacts.
-
Concussion and Traumatic Encephalopathy Syndrome (January 2022 Neurology Recall)
01/01/2022 Duration: 34minThe January 2022 replay of past episodes showcases a selection of interviews regarding the diagnosis and effects of traumatic encephalopathy syndrome (TES) and concussions. This episode features Dr. Alex Menze in conversation with Dr. Robert Stern, Dr. Nathan Churchill, and Prof. Antonio Belli, offering listeners a comprehensive understanding of the diagnosis and management of head trauma.
-
70th Anniversary Interviews, Part II
27/12/2021 Duration: 25minCelebrate the 70th Anniversary of Neurology® with Part II of a series of interviews on the history of the journal featuring editors-in-chief Drs. José Merino, Robert Gross, John Noseworthy, and Robert Griggs as well as Podcast Editors Drs. Ted Burns and Stacey Clardy.
-
70th Anniversary Interviews, Part I
21/12/2021 Duration: 26minCelebrate the 70th Anniversary of Neurology® with Part I of a series of interviews on the history of the journal featuring editors-in-chief Drs. José Merino, Robert Gross, John Noseworthy, and Robert Griggs as well as Podcast Editors Drs. Ted Burns and Stacey Clardy.
-
Effectiveness of Initial Treatment for Infantile Spasms; CNS Hereditary Amyloidosis
13/12/2021 Duration: 25minIn the first part of the podcast, Dr. Halley Alexander discusses the effectiveness of the three first line treatments for infantile spasms with Dr. Zachary Grinspan (00:51). In the second segment, Dr. Gordon Smith talks with Dr. Ricardo Taipa about the clinical manifestations, imaging results, and neuropathological findings associated with CNS involvement in hereditary transthyretin amyloidosis (14:53).
-
COVID Vaccines and Neurology Immunotherapy; Health Disparities in Stroke Interventions
06/12/2021 Duration: 31minIn the first part of the podcast, Dr. Justin Abbatemarco talks with Dr. Avi Nath, Director of the National Institute of Neurological Disorders and Stroke at the National Institutes of Health, about COVID-19 vaccines and neurology immunotherapy (00:56). In the second segment, Dr. Andy Southerland discusses disparities in the utilization of stroke interventions with Dr. Adam de Havenon (18:18).
-
Common Issues in Stroke Management (December 2021 Neurology Recall)
01/12/2021 Duration: 52minThe December 2021 replay of past episodes showcases a selection of interviews regarding the diagnosis and management of stroke. This episode features Dr. Andy Southerland and Will Rondeau in conversation with Drs. Seemant Chaturvedi, Lee Schwamm, Jyri Virta, and Sidsel Hastrup, offering listeners a review across the field of vascular neurology.
-
Small Fiber Neuropathy; Representation of Women in Stroke Clinical Trials
29/11/2021 Duration: 26minIn the first part of the podcast, Dr. Stacey Clardy talks with Dr. Christopher Klein about small fiber neuropathy incidence, prevalence, longitudinal impairments, and disabilities (00:45). In the second segment, Dr. Amy Guzik discusses the representation of women in stroke clinical trials relative to the burden of disease in the population with Dr. Cheryl Carcel (16:12).
-
International Headache Congress 2021; Speech Subtypes in Parkinson Disease
22/11/2021 Duration: 20minIn the first part of the podcast, Dr. Tesha Monteith discusses the International Headache Society and European Headache Federation 2021 joint International Headache Congress with Dr. Patricia Pozo-Rosich (00:45). In the second segment, Dr. Jeff Ratliff talks with Dr. Jan Rusz about identifying speech subtypes in patients with Parkinson disease in response to long-term dopaminergic therapy (8:18).
-
Dopamine Therapy in Early PD; Neurologic Disease Definitions with Immune Checkpoint Inhibitors
15/11/2021 Duration: 26minIn the first part of the podcast, Dr. Jason Crowell discusses the AAN Guideline Subcommittee's practice guideline summary on dopaminergic therapy for motor symptoms in early Parkinson disease with Dr. Anthony Lang (00:45). In the second segment, Dr. Kathryn Nevel talks with Dr. Amanda Guidon about the development of consensus disease definitions for neurologic immune-related adverse events associated with immune checkpoint inhibitors (17:04).
-
Chronic Meningitis; MS Therapies and COVID-19
08/11/2021 Duration: 41minIn the first part of the podcast, Dr. Stacey Clardy discusses the causes, features, evaluation, and treatment of chronic meningeal inflammation or infection with Dr. Allen Aksamit. In the second segment, Dr. Eoin Flanagan talks with Dr. Tomas Kalincik about the associations of disease-modifying therapies with COVID-19 severity in multiple sclerosis (26:48).
-
Aducanumab: What About the Patient?; Risk of Aneurysm Rupture After Stroke Thrombolysis
01/11/2021 Duration: 25minIn the first part of the podcast, Dr. Gregg Day discusses the importance of patient participation in the decision-making process when considering the use of aducanumab for the treatment of Alzheimer disease with Dr. Ron Petersen, Director of the Mayo Clinic Alzheimer’s Disease Center. In the second segment, Dr. Andy Southerland talks with Dr. Jyri Virta about the risk of aneurysm rupture after thrombolysis in patients with acute ischemic stroke and unruptured intracranial aneurysms.
-
-
Aducanumab and the Business of Alzheimer Disease; Implicit Light Sensitivity in Migraine
25/10/2021 Duration: 20minIn the first part of the podcast, Dr. Jason Crowell discusses the business of Alzheimer disease and how to approach teaching patients about aducanumab with Dr. Jason Karlawish. In the second segment, Dr. Jennifer Bickel talks with Dr. Eric Kaiser about the contribution of melanopsin and cone signals to light-induced reflexive eye closure in migraine.
-
Neurologic Safety of COVID-19 Vaccines; Movement Disorders in Anti-IgLON5 Disease
18/10/2021 Duration: 30minIn the first part of the podcast, Dr. Jason Crowell talks with Dr. Kiran Thakur about the importance of monitoring COVID-19 vaccines for neurologic adverse events and learning from past vaccination programs. In the second segment, Dr. Jeff Ratliff interviews Dr. Carles Gaig about the frequency and types of movement disorders in patients with anti-IgLON5 disease.
-
CRISPR-Cas9 for TTR Amyloidosis; Osmotic Demyelination Syndrome
11/10/2021 Duration: 22minIn the first part of the podcast, Dr. Alberto Espay talks with Prof. Julian Gillmore about CRISPR-Cas9 in vivo gene editing for transthyretin amyloidosis. In the second segment, Dr. Pearce Korb discusses the long-term outcomes of osmotic demyelination syndrome in an updated cohort with Dr. Whitney Fitts.